Stereotaxis Reports 2022 Third Quarter Financial Results
ST. LOUIS, Nov. 10, 2022 (GLOBE NEWSWIRE) — Stereotaxis (NYSE:STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today reported financial results for the third quarter ended September 30, 2022.
Related news for (STXS)
- MoBot alert highlights: NASDAQ: GTI, NASDAQ: VWAV, NASDAQ: ADIL, NYSE: STXS, NASDAQ: ABP (07/28/25 08:00 AM)
- Stereotaxis Receives U.S. FDA Clearance for MAGiC Sweep Catheter
- 24/7 Market News Snapshot 28 July, 2025 – Stereotaxis, Inc. Common Stock (NYSE:STXS)
- Stereotaxis Reports 2025 First Quarter Financial Results
- Stereotaxis to Feature First-Ever Live Demo of GenesisX Robotic System at HRS 2025
